Afferden, Netherlands

Johannes Egbertus Maria Basten

This inventor holds 2 USPTO granted patents. Top assignees: Akzo Nobel N.v., Other. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes Egbertus Maria Basten. Retrieved from https://idiyas.com/inventor/johannes-egbertus-maria-basten

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Johannes Egbertus Maria Basten: Innovator in Antithrombotic Compounds

Introduction

Johannes Egbertus Maria Basten is a notable inventor based in Afferden, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antithrombotic compounds. With a total of 2 patents to his name, Basten's work has the potential to impact the medical community positively.

Latest Patents

Basten's latest patents include innovative antithrombotic compounds derived from carbohydrate derivatives. The invention relates to a carbohydrate derivative having formula I, which showcases his expertise in creating compounds that may enhance therapeutic options for patients at risk of thrombotic events.

Career Highlights

Throughout his career, Basten has worked with prominent companies, including Akzo Nobel N.V. His experience in the industry has allowed him to apply his research in practical settings, contributing to advancements in pharmaceutical development.

Collaborations

Basten has collaborated with esteemed colleagues such as Constant Adriaan Anton Van Boeckel and Cornelia Maria Dreef-Tromp. These partnerships have likely enriched his research and broadened the scope of his inventions.

Conclusion

Johannes Egbertus Maria Basten is a distinguished inventor whose work in antithrombotic compounds demonstrates his commitment to advancing medical science. His contributions are valuable to the ongoing development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…